Shanghai MicuRx advances MRX-4 trial results towards NDA approval
Shanghai MicuRx Pharmaceutical Co., Ltd. has announced a major breakthrough in antibacterial drug development, successfully completing its Phase III clinical trial of MRX-4 for injection ... Read More
Sun Pharma introduces STARIZO to tackle drug-resistant skin infections in India
Sun Pharmaceutical Industries Limited has introduced STARIZO (Tedizolid Phosphate) to the Indian market, a novel antibacterial treatment targeting Acute Bacterial Skin and Skin Structure Infections ... Read More